The skin allergy drug zolivex, approved by the US Food and Drug Administration in 2015, has been used to treat anaphylaxis in a number of studies.
It has been linked to an increase in allergic reactions in some people with a skin allergy, including in older people.
In one study of adults, the drug’s most recent efficacy report for a person who had a skin reaction was a 10 per cent increase in the number of positive reaction rates.
Zolive x is not approved for use in children.
But one Australian research group says that zolitex may help to treat the skin allergy symptoms of some people in older age.
A team of researchers from the University of Melbourne’s Faculty of Medicine and Dentistry studied zolivax, which was originally marketed as Zoltec.
The drug was found to be effective in the treatment of anaphyleptic dermatitis and an allergic reaction in adults aged 65 and older.
“It was found that zlx reduced symptoms of an allergic dermatitis in the elderly,” said lead author Dr Julie Wood, an associate professor of dermatology at the university.
Dr Wood said the drug worked well when taken daily and could be used as a daily supplement for people with anaphysiological reactions.
People with more severe allergies may also benefit from zolives treatment, she said.
“Zolivx has been shown to have anti-inflammatory properties, which may be useful for those who have inflammatory reactions,” Dr Wood said.
Professor Wood said she was excited about the potential of zoliftx for people who have had skin allergies before.
She said the team would continue to monitor the drug in people with skin allergies and the results would be published in a future publication.
But the drug is only available as a supplement for individuals with skin reactions, not as a cure.
An alternative drug for the allergy, Zolive X is approved by both the FDA and the Australian Food and Pharmaceuticals Safety Authority.
Read more about skin allergy: